GLP-1 receptor agonists for smoking cessation: a narrative review of weight management potential.

Although the primary endpoint 12-month smoking abstinence did not reach statistical significance, secondary outcomes were encouraging: dulaglutide was associated with reduced nicotine cravings, less post-cessation weight gain, and higher self-reported satisfaction with the quitting process [ 54 ] .

also in 111,027 other papers